Vericel Corporation
Symbol: VCEL (NASDAQ)
34.24
▲ (2.07%) 0.694
Company Description:
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Key Stats
- Today's Open: $33.42
- Today's High: $35.604
- Today's Low: $33.121
- Today's Volume: 1.13M
- Yesterday Close: $33.55
- Yesterday High: $34.83
- Yesterday Low: $33.34
- Yesterday Volume: 882.29K
- Last Min Volume: 0
- Last Min High: $34.244
- Last Min Low: $33.72
- Last Min VWAP: $0
Company Profile
- Name: Vericel Corporation
- Website: https://www.vcel.com
- Listed Date: 1997-02-04
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0000887359
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $1.69B
- Round Lot: 100
- Outstanding Shares: 50.46M
- Asset Type: CS
RECENT FILINGS FOR VCEL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-08-08 | 4 | View |
| 2025-08-06 | 144 | View |
| 2025-07-31 | 10-Q | View |
| 2025-07-31 | 8-K | View |
| 2025-06-04 | 4 | View |
| 2025-06-02 | 144 | View |
| 2025-05-30 | 144 | View |
| 2025-05-16 | 4 | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | 144 | View |
| 2025-05-14 | 144 | View |
| 2025-05-09 | 4 | View |
| 2025-05-08 | S-8 | View |
| 2025-05-08 | S-8 | View |
| 2025-05-08 | 10-Q | View |
| 2025-05-08 | 8-K | View |
| 2025-05-07 | 144 | View |
| 2025-05-02 | 4 | View |
Latest News on VCEL